Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study - Concepedia

Concepedia

Publication | Open Access

Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study

DOI Full Paper Access

237

Citations

22

References

2018

Year

Kenji Kabashima, Masutaka Furue, Jon M. Hanifin, Grażyna Pulka, Andreas Wollenberg, Ryszard Galus, Takafumi Etoh, Ryosuke Mihara, Miwa Nakano, Thomas Ruzicka

Journal of Allergy and Clinical Immunology

References

	Year	Citations

Page 1